Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors

  • Martin Neumann,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Ebru Coskun,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Lars Fransecky,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Liliana H. Mochmann,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Isabelle Bartram,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Nasrin Farhadi Sartangi,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Sandra Heesch,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Nicola Gökbuget,

    Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany

  • Stefan Schwartz,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Christian Brandts,

    Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany

  • Cornelia Schlee,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Rainer Haas,

    Affiliation Department of Hematology and Oncology, University of Düsseldorf, Düsseldorf, Germany

  • Ulrich Dührsen,

    Affiliation Department of Hematology and Oncology, University of Essen, Essen, Germany

  • Martin Griesshammer,

    Affiliation Department of Hematology and Oncology, Klinikum Minden, Minden, Germany

  • Hartmut Döhner,

    Affiliation Department of Internal Medicine III, University of Ulm, Ulm, Germany

  • Gerhard Ehninger,

    Affiliation Department of Hematology and Oncology, University of Dresden, Dresden, Germany

  • Thomas Burmeister,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Olga Blau,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Eckhard Thiel,

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • Dieter Hoelzer,

    Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany

  • Wolf-Karsten Hofmann,

    Affiliation University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany

  •  [ ... ],
  • Claudia D. Baldus

    claudia.baldus@charite.de

    Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.